BioSpace News Archive

Neurogene Inc., a company founded with a mission to bring life-changing medicines to patients and families affected by rare neurological diseases, today announced the appointment of Christine Mikail as President

Greenleaf Health, Inc., a leading Food and Drug Administration (FDA) regulatory consulting firm, today announces that the firm has expanded its portfolio of services to guide companies developing cell and gene therapy products

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced several presentations at SynBioBeta 2019, the leading industry conference bringing together biological engineers, investors, innovators and entrepreneurs to build a better world with biology, to be held October 1-3 in San Francisco, California.

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that the U.S. Food and Drug Administration (FDA) has granted fast track designation to ADX-2191 for the prevention of proliferative vitreoretinopathy (PVR).

Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on the development and commercialization of therapeutics for people living with kidney disease, today announced that John P. Butler, President and Chief Executive Officer of Akebia, will present at the 2019 Cantor Global Healthcare Conference at 8:55 a.m. ET on Thursday, October 3, 2019 in New York City.

Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it has dosed the first patients in its Phase 3 clinical trial of DEXTENZA® for the treatment of symptoms of allergic conjunctivitis (AC).

First-of-its-kind comparative analysis of real-world data in the CDK 4/6 inhibitor class supports benefits of IBRANCE combination therapy initially shown in clinical trials

29th International Congress of the European Respiratory Society (ERS) being held September 28th - October 2nd in Madrid, Spain.

Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., announced that data from its company-sponsored survey, titled “How America Sleeps and Wakes,” was presented at the 2019 World Sleep Congress in Vancouver, Canada.

Accelify Solutions, LLC (Accelify), a leading provider of special education management systems, will be presenting at the upcoming National Alliance for Medicaid in Education (NAME) conference on Thursday, October 3rd, 2019 at the Hyatt Regency in Albuquerque, NM.